Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 16, 2024
RNS Number : 5706W Stifel Nicolaus Europe Limited 16 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 15, 2024
RNS Number : 3963W Stifel Nicolaus Europe Limited 15 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Issue of Shares and Rule 2.9 Announcement

July 15, 2024
RNS Number : 3140W Renalytix PLC 15 July 2024   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares and Rule 2.9 Announcement   LONDON and NEW YORK -   July 15, 2024 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the principal amount of the

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 12, 2024
RNS Number : 2142W Stifel Nicolaus Europe Limited 12 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 11, 2024
RNS Number : 0325W Stifel Nicolaus Europe Limited 11 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Steno Diabetes Center (Copenhagen) Collaboration

July 11, 2024
RNS Number : 9992V Renalytix PLC 11 July 2024   Renalytix plc ("Renalytix" or the "Company")   Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US   LONDON and NEW YORK , July 11, 2024   - Renalytix plc (NASDAQ:

Holding(s) in Company

July 10, 2024
RNS Number : 9212V Renalytix PLC 10 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYWL4Y04 Issuer Name RENALYTIX PLC UK or Non- UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3.

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 10, 2024
RNS Number : 8504V Stifel Nicolaus Europe Limited 10 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 9, 2024
RNS Number : 6815V Stifel Nicolaus Europe Limited 09 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

July 8, 2024
RNS Number : 4844V Stifel Nicolaus Europe Limited 08 July 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of
Displaying 1 - 10 of 441